1033040-23-1
中文名称 | 1033040-23-1 |
---|---|
中文同义词 | 化合物 T17146 |
英文名称 | TPO agonist 1 |
英文同义词 | TPO agonist 1;1H-Pyrazole-4,5-dione, 1-(3,4-dimethylphenyl)-3-methyl-, 4-[2-[2-hydroxy-3'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-3-yl]hydrazone] |
CAS号 | 1033040-23-1 |
分子式 | C25H22N8O2 |
分子量 | 466.49 |
EINECS号 | |
相关类别 | |
Mol文件 | 1033040-23-1.mol |
结构式 |
1033040-23-1 性质
沸点 | 703.5±70.0 °C(Predicted) |
---|---|
密度 | 1.42±0.1 g/cm3(Predicted) |
酸度系数(pKa) | 4.25±0.10(Predicted) |
形态 | 固体 |
颜色 | 粉红至红色 |
TPO receptor
The thrombopoietin (TPO) receptor agonists are novel treatments for patients with chronic ITP aimed at increasing platelet production through interactions with the TPO receptor on megakaryocytes, and can increases platelet counts, decrease bleeding events and reduce the need for adjunctive or rescue treatments. The TPO receptor agonists are well-tolerated, though uncertainty remains regarding the risk of thromboembolism and bone marrow fibrosis.
安全信息
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/08/19 | HY-100380 | 1033040-23-1 TPO agonist 1 | 1033040-23-1 | 2mg | 1000元 |
2024/08/19 | HY-100380 | 1033040-23-1 TPO agonist 1 | 1033040-23-1 | 5mg | 1400元 |